Halper Sadeh LLC Investigates Supernus, Integer, and Bowhead Deals for Shareholder Fairness

M&A · PartnershipRegulation

โดย GlobeNewswire·Read original

Summary · why it matters

Halper Sadeh LLC, an investor rights law firm, is investigating whether the proposed acquisitions of Supernus Pharmaceuticals, Integer Holdings, and Bowhead Specialty Holdings are fair to shareholders. The firm is examining Supernus Pharmaceuticals' sale to Indivior Pharmaceuticals for 1.5401 common shares of Indivior per Supernus share, Integer Holdings' sale to KKR for $127.00 per share, and Bowhead Specialty Holdings' sale to American Family Mutual Insurance Company for $34.00 per share in cash. Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief on behalf of shareholders, and encourages investors to contact the firm to discuss their rights at no cost.

Bowhead Specialty Holdings Inc. ±

Integer Holdings Corp ±

Supernus Pharmaceuticals Inc ±

Indivior PLC Ordinary Shares ±

KKR & Co. Inc. ±

Impact on stocks 5

Biotech & Genomic Medicine▲ · 2 stocks

Supernus Pharmaceuticals Inc

± MixedCapitalrelevance

Sale to Indivior for 1.5401 shares per share; investigation may seek better terms.

Indivior PLC Ordinary Shares

± MixedCapitalrelevance

Acquiring Supernus in a stock deal; investigation could impact deal consideration.

Financials▲ · 1 stocks

Bowhead Specialty Holdings Inc.

± MixedCapitalrelevance

Acquisition by American Family Mutual Insurance at $34.00 per share; investigation may affect deal terms.

Brain-Computer Interface▲ · 1 stocks

Integer Holdings Corp

± MixedCapitalrelevance

Sale to KKR at $127.00 per share; investigation may seek increased consideration.

Aging Population▲ · 1 stocks

± MixedCapitalrelevance

Acquiring Integer Holdings; investigation may affect deal terms.

Off-coverage companies 1

American Family InsurancePrivate± Mixed

relevance